ELAVL1 and laryngotracheoesophageal cleft: Our findings suggested that paclitaxel and docetaxel had negative correlations with ELAVL1, HNRNPC and RBM15B, which meant paclitaxel and docetaxel were sensitive to ELAVL1, HNRNPC and RBM15B in LC.